(Q53144362)

11 May 2018

meta-analysis

0 references

title

Positive association between circulating 25-hydroxyvitamin D levels and prostate cancer risk: new findings from an updated meta-analysis. (English)

1 reference

11 May 2018

0 references

1 reference

Yonghua Xu

1

1 reference

11 May 2018

Xiaoping Shao

2

1 reference

11 May 2018

Yacheng Yao

3

1 reference

11 May 2018

Lijian Xu

4

1 reference

11 May 2018

Liang Chang

5

1 reference

11 May 2018

Zhuojuan Jiang

6

1 reference

11 May 2018

Zhaofen Lin

7

1 reference

11 May 2018

publication date

17 May 2014

1 reference

11 May 2018

Journal of Cancer Research and Clinical Oncology

published in

1 reference

11 May 2018

volume

140

1 reference

11 May 2018

issue

9

1 reference

11 May 2018

page(s)

1465-1477

1 reference

11 May 2018

https://scigraph.springernature.com/pub.10.1007/s00432-014-1706-3

exact match

0 references

cites work

Serum vitamin D concentration and prostate cancer risk: a nested case-control study

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1706-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1706-3

Serum insulin, glucose, indices of insulin resistance, and risk of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1706-3

Serum 25-hydroxy vitamin D and prostate cancer risk in a large nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1706-3

Estimation of total usual calcium and vitamin D intakes in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1706-3

Serum 25-OH vitamin D levels and risk of developing prostate cancer in older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1706-3

Risk of prostate cancer in a randomized clinical trial of calcium supplementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1706-3

Operating characteristics of a rank correlation test for publication bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1706-3

Effect of Vitamin D on falls: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1706-3

Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1706-3

Vitamin D, PTH, and calcium and the risk of prostate cancer: a prospective nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1706-3

Prostate cancer and prediagnostic levels of serum vitamin D metabolites (Maryland, United States)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1706-3

Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1706-3

A U-shaped relationship between plasma folate and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1706-3

Vitamin D signalling pathways in cancer: potential for anticancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1706-3

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1706-3

Vitamins and prostate cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1706-3

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1706-3

Vitamin D and cardiovascular outcomes: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1706-3

Lack of association between serum levels of 25-hydroxyvitamin D and the subsequent risk of prostate cancer in Finnish men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1706-3

Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1706-3

Associations of circulating and dietary vitamin D with prostate cancer risk: a systematic review and dose-response meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1706-3

Associations of circulating 25-hydroxyvitamin D with prostate cancer diagnosis, stage and grade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1706-3

The epidemiology of vitamin D and cancer incidence and mortality: a review (United States).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1706-3

25-hydroxyvitamin D, IGF-1, and metabolic syndrome at 45 years of age: a cross-sectional study in the 1958 British Birth Cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1706-3

Plasma levels of 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and the risk of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1706-3

Folate: a magic bullet or a double edged sword for colorectal cancer prevention?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1706-3

Chemoprevention of colon cancer by calcium, vitamin D and folate: molecular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1706-3

A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1706-3

Folic acid fortification: a double-edged sword

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1706-3

Vitamin D, season, and risk of prostate cancer: a nested case-control study within Norwegian health studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1706-3

22-Oxa-1alpha,25-dihydroxyvitamin D3 inhibits metastasis and angiogenesis in lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1706-3

Serum vitamin D metabolite levels and the subsequent development of prostate cancer (Hawaii, United States)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1706-3

Serum 25-Hydroxyvitamin D and Cancer Risk in Older Adults: Results from a Large German Prospective Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1706-3

Plasma 25-hydroxyvitamin D and prostate cancer risk: the multiethnic cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1706-3

The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1706-3

Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and subsequent risk of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1706-3

Seasonal and geographical variations in lung cancer prognosis in Norway. Does Vitamin D from the sun play a role?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1706-3

Serum 25-hydroxyvitamin D levels and overall mortality. A systematic review and meta-analysis of prospective cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1706-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1706-3

21 January 2018

Cancer statistics, 2014

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1706-3

Serum vitamin D and risk of prostate cancer in a case-control analysis nested within the European Prospective Investigation into Cancer and Nutrition (EPIC)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1706-3

Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: A longitudinal, nested case‐control study in the Nordic countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1706-3

Meta-analysis of longitudinal studies: Serum vitamin D and prostate cancer risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1706-3

Circulating 25-hydroxyvitamin D serum concentration and total cancer incidence and mortality: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1706-3

Serum 25-hydroxyvitamin D and prevention of breast cancer: pooled analysis.

21 January 2018

1 reference

12 December 2020

A prospective study of dietary calcium, dairy products and prostate cancer risk (Finland)

1 reference

12 December 2020

The association of solar ultraviolet B (UVB) with reducing risk of cancer: multifactorial ecologic analysis of geographic variation in age-adjusted cancer mortality rates.

1 reference

12 December 2020

Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study

1 reference

12 December 2020

Vitamin D receptor polymorphisms, circulating vitamin D metabolites, and risk of prostate cancer in United States physicians.

1 reference

12 December 2020

Vitamin D in colorectal, breast, prostate and lung cancer: a pilot study

1 reference

12 December 2020

Interaction of factors related to the metabolic syndrome and vitamin D on risk of prostate cancer

1 reference

12 December 2020

Statistical aspects of the analysis of data from retrospective studies of disease

1 reference

12 December 2020

Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy

1 reference

12 December 2020

Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland)

1 reference

12 December 2020

Understanding prostate cancer.

1 reference

12 December 2020

Vitamin D receptor (VDR) gene polymorphisms and haplotypes, interactions with plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D, and prostate cancer risk

1 reference

12 December 2020

10.1007/S00432-014-1706-3

Identifiers

DOI

1 reference

11 May 2018

PubMed ID

24838848

1 reference

11 May 2018